Osteoarthritis is the most common form of arthritis, affecting close to five million Canadians. Common symptoms include joint pain, aching, morning stiffness, swelling, and reduced range of movement in the affected joints.
“While the disease generally progresses over time, research is bringing hope for people affected by the disease,” says Trish Barbato, president and CEO of the Arthritis Society.
Thanks to Canadian research funded by the Arthritis Society, there is good news on the horizon.
Researchers in Calgary are discovering a network of molecules in the blood that are linked to osteoarthritis. If they find a way to block one of the key molecules, it may be able to prevent cartilage damage and the progression of the disease.
Osteoarthritis drugs that circulate through the whole body often have undesirable side effects. Researchers in London are developing a way to convert an anti-inflammatory drug into tiny particles and inject it straight into a joint, minimizing the side effects and maximizing the benefits.
A research team in Toronto has launched a clinical trial injecting cells from a patient’s bone marrow directly into their knee to reduce inflammation and pain. This could be a game-changer for the safe delivery of life-altering medication.
Source – www.newscanada.com